A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse

British Journal of Haematology

Volumn 98, Issue 1, 1997, Pages 140-146

  Jacquy, C ^a   Delepaut, B ^a   Van Daele, S ^a   Vaerman, J L ^a   Zenebergh, A ^a   Brichard, B ^a   Vermylen, C ^a   Cornu, G ^a   Martiat, P ^a,b  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b Haematology Unit   (Belgium)

Author keywords

ALL; MRD; PCR; Prognosis

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; FEMALE; GENE REARRANGEMENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030793472     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.1792996.x     Document Type: Article

References (37)

1. Aubin, J., Davi, F., Nguyen-Salomon, F., Leboeuf, D., Debert, C., Taher, M., Valensi, F., Canioni, D., Brousse, N., Varet, B., Flandrin, G. & Macintyre, E. (1995) Description of a novel FR1 IGH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia, 9, 47-479.
2. Beishuizen, A., Verhoeven, MA., Van Wering, E., Hahlen, K., Hooijkaas, H. & Van Dongen, J. (1994) Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. Blool. 83, 2238-2247.
3. Biondi, A., Rambaldi, A., Rossi, V, Elia, L., Caslini, C., Basso, G., Battista, R., Barbui, T., Mandelli, F., Masera, G., Croce, C., Canaani, E. & Cimino, G. (1993) Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4:11). Blood, 82, 2943-2948.
4. Brisco, M., Condon, J., Hughes, E., Neoh, S,. Sykes, P., Seshadri, R., Toogood, I., Waters, K., Tauro, G., Ekert, H. & Morley, A. (1994) Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction. Lancet, 343, 196-200.
5. Brisco, M.J., Hughes, E., Neoh, S.H., Sykes, P.J., Bradstock, K., Enno, A., Szer, J., McCaul, K. & Morley, A. (1996) Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood, 87, 5251-5256.
6. Cavé, H., Bakkus, M., Suciu, S., Guidal, C., Fournier, M. Robert, A., Boutard, P., Mechinaud, F., Plouvier, E., Eerster, A., Nelken, B., Otten, J., Thielemans, K., Grandchamp, B. & Vilmer, E. (1995) The EORTC Children Eeukemia Cooperative Group: Significance of the quantitation of minimal residual disease by PCR amplification of IgH and TCR gene rearrangements in childhood ALL. Blood, 86, (Suppl. 1), 178a (abstr. 699).
7. Cavé, H., Guidai, C., Rohrlich, P., Delfau, M.H., Broyart, A., Lescoeur, B., Rahimy, C., Fenneleau, O., Monplaisir, N., d'Auriol, L., Elion, J., Vilmer, E. & Grandchamp, B. (1994) Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. Blood, 83, 1892-1902.
8. Chim, J., Coyle, L., Yaxley, J., Cole-Sinclair, M., Cannell, P., Hoffbrand, V. & Foroni, E. (1996) The use of IGH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL. British Journal of Haematology, 92, 104-115.
9. Crist, W., Boyett, J., Pullen, J., van Eys, J. & Vietti, T. (1986) Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: a Pediatric Oncology Group Review. Medical Pediatric Onocology, 14, 135-139.
10. Estrov, Z., Grunberger, T., Dube, L. Wang, Y.P. & Freedman, M. (1986) Detection of residual acute lymphoblastic leukemia cells in culture bone marrow obtained during remission. New England Journal of Medicine. 315, 538-542.
11. Gaynon, P.S., Bleyer, W.A., Steinherz, P.G., Finkelstein, J.Z., Littman. P., Miller, D.R., Reaman, G., Sather, H. & Hammond, G.D. (1990) Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features. Mcdical Pediatric Oncology. 18, 273-279.
12. Grun, B., Yi, H., Kitchingman. G.R. & Hongeng, S. (1996) low to undetectable levels of MRD using a semi-nested polymerase chain reaction after intensive induction therapy in childhood Blineage ALL. Blood. 86, (Suppl. 1), 478a (abstr. 1902).
13. Hammond, D., Sather, H., Nesbit, M., Miller, D., Coccia, P., Bleyer, A., Lukers, J. & Siegel, S. (1986) Analysis of prognostic factors in acute lymphoblastic leukemia. Medical Pediatric Oncology. 14, 124-134.
14. Hansen-Hagge, T., Yokota, S. & Bartram, C. (1989) Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences. Blood, 74, 1762-1767.
15. Hunger, S.P., Galili, N., Carroll, A.J., Crist, W.M., Link, M.P. & Cleary, M.L.L. (1991) The t(1:19)(q23:p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood, 77, 687-693.
16. Landman-Parker, J., Aubin, J., Delabesse, F., Tabone, M.D., Adam, M., Millien, C., Leboeuf, D., Buzynveil, A., Dolfuss, C., Leverger, G. & Macintyre, E. (1996) Simplified strategies for minimal residual disease detection in B-cell precursor acute lymphoblastic leukaemia. British Journal of Haematology. 95, 281-290.
17. Martiat, P., Maisin, D., Philippe, M., Ferrant, A., Michaux. J.L., Cassiman, J.J., Van den Berghe, H. & Sokal, G. (1990) Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction with nested primers. British Journal of Haematology. 75, 355-358.
18. Maurer, J., Janssens, J.W., Thiel, E., Van denderen, J.V., Ludwig, W.D., Aydemir, U., Heize, B., Fonatsch, C., Harbott, J., Reiter, A., Riehm, R., Hoelzer, D. & Bartram, C.R. (1991) Detection of chimeric BCRABL genes in acute lymphocytic leukaemia by the polymerase chain reaction. Lancent, 337, 1055-1058.
19. Miller, D.R., Coccia, P.F., Bleyer, W.A., Lukens, J.N., Siegel, S.E., Sather, H.N. & Hammond, G.D. (1989) Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute leukemia: a report from the Childrens Cancer Study Group. Journal of Clinical Oncology. 7, 1807-1815.
20. Nizet, Y., Martiat, P., Vaerman, J.L., Philippe, M., Wildmann, C., Staelens, J.P., Cornu, G., Ferrant, A., Michaux, J.L. & Sokal, G. (1991) Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy, evolution of MRD rather than its detection is correlated with clinical outcome. British Journal of Haematology. 79, 205-210.
21. Nizet, Y., Van Daele, S., Lewalle, P., Vaerman, J.L., Philippe, M., Vermylen, C., Cornu, G., Ferrant, A., Michaux. J.L. & Martiat, P. (1993) Long-term follow-up ot residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IGH probes and the polymerase chain reaction. Blood. 82, 1618-1625.
22. Ouspenskaia, M., Johnston, D., Roberts, W., Estrov, Z. & Zipf, T. (1995) Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved. Leukemia, 9, 321-328.
23. Poirel, H., Rack, K., Delabesse, E., Radford-Weiss, I., Troussard, X., Debert, C., Leboeuf, D., Bastard, C., Picard, F., Veil-Buzyn, A., Flandrin, G., Bernard, O. & Macintyre, E. (1996) Incidence and characterization of MLL gene rearrangements in acute myeloid leukemia M1 and M5. Blood, 87, 2496-2505.
24. Pui, C. H. Rivera, G.K., Hancock, M.L., Raimondi, S.C., Sandlund, J.T., Mahmoud, H.H., Ribeiro, R.C., Furman, W.L., Hurwitz, C.A. & Crist, W.M. (1993) Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. Leukemia, 7, 35-40.
25. Riehm, H., Reiter, A., Schrappe. M., Berthold, F., Dopfer, R., Gcrein,V., Ludwig, R., Ritter, J., Slollman, B. & Henze, G. (1987) Corticostcroid dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in clildhood (therapy study ALL-BFM 83). Klinisches Pädiatrie, 199, 151-160.
26. Rivera, G.K., Pinkel, D., Simone, J.V., Hancock, M.L. & Crist, W.M. (1993) Treatment of acute lymphoblastic leukemia: 30 years experience at St. Judes Children's Research Hospital. New England Journal of Medicine. 529, 1289-1295.
27. Roberts, W., Estrov, Z., Ouspenskaia, M., Papusha, V., Johnston, D., Harris, D., McClain, K. & Zipf, T. (1995) Measurement of treatment response by quantitative PCR during remission in childhood ALL. Blood, 86. (Suppl. 1), 177a (abstr. 696).
28. Schrappe, M., Reiter, A., Sauter, S., Ludwig, W.D., Wormann. B., Harbott. J., Bender-Gotze, C., Dorffel, W., Dopfer, R., Frey, R., Riehm, H. & Henze, G. (1994) Concept and interim study of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow. Klinische Pädiatrie. 206, 208-221.
29. Shurtleff, S.A., Buijs, A., Hehm, KG., Rubnitz, J.E., Raimondi, S.C., Hancock, M.L., Chan, G-F., Pui, C.H., Grosveld, G. & Downing, J.R. (1995) TEL/AML1 fusion resulting from a cryptic t(12:21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis, leukemia, 9. 1985-1989.
30. Steinherz, P.G., Gaynon, P.S., Breneman. J.C., Cherlow, J.M., Grossman. N.J., Kersey, J.H., Johnstone, U.S., Sather, H.N., Trigg, M.E., Chappel, R., Hammond, D. & Bleyer, W.A. (1996) Cytoreduction and prognosis in acute lymphoblastic leukemia: the importance of early marrow response, Journal of Clinical Oncology, 14, 389-398.
31. Steward, C., Goulden, N., Katz, F. Baines, D., Martin, P., Langlands, K., Potter, M., Chessells, J. & Oakhill, A. (1994) A polymenise chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood, 83, 1355-1362.
32. Sykes, P.J., Neoh, S.H., Brisco. M.J., Hugbes, E., Condon, J. & Morky, A.A. (1992) Quantitation of targets for PCR by use of limiting dilution. Bioteclmiques, 13, 444-148.
33. Uckun, K. Kersey, J., Haake, R., Weisdorf, D., Nesbit, M. & Ramsay, N. (1993) Pretransplantation burden of leukemic progenitor cells as a predictor of relapse alter bone marrow transplantation for acute lymphoblastic leukemia. New England Journal of Medicine. 329, 1296-1301.
34. Van Dongen, J. & San Miguel, J. (1996) Techniques for detection of minimal residual disease in leukaemia patients. Meet the Expert Sessions of the Second Meeting of the European Haematology Association. pp. 39-46. Blackwell Science, Oxford.
35. Van Rhee, F., Marks, D., Lin, F., Szydlo, R., Hochhaus, A., Treleaven, J., Delord, C., Cross, N. & Goldman, J.M. (1995) Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia:comparison of blood and bone marrow. Leukemia. 9, 329-335.
36. Wasserman, R., Galili, N., Ito, Y., Silber, J., Reichard, B., Shane, S., Womer, R.B., Lange, B. & Rovera, G. (1992) Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia, Journal of Clinical Oncology. 10, 1879-1888.
37. Yokota, S., Hansen-Hagge, T., Ludwig, W.D., Reiter, A., Raghavachar, A., Kleihauer, E. & Bartram, C. (1991) Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood, 77, 331-339.